Home / Atazanavir / Canada
CA ATC J05AE08 · updated 2 Nov 2026
Atazanavir shortage in Canada
Is there an Atazanavir shortage in Canada?
Yes. As of 2 Nov 2026, 4 Atazanavir products are reported short in Canada, the first since 3 Aug 2021. No return date has been given. Main reason: manufacturing problem.
Also short in Spain. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MYLAN-ATAZANAVIR (30BT) | MYLAN PHARMACEUTICALS ULC | 3 Aug 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-ATAZANAVIR (60BT) | MYLAN PHARMACEUTICALS ULC | 3 Aug 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-ATAZANAVIR (60BT) | MYLAN PHARMACEUTICALS ULC | 7 Sep 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | REYATAZ (1 X 60) discontinuation | BRISTOL-MYERS SQUIBB CANADA | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.